European Commission to monitor inflation
This article was originally published in Clinica
Executive Summary
Pharmacy products are likely to be among the first group of consumer goods to have their costs monitored by National Statistics Offices within the context of consumer price indices. The European Commission will prepare a series of Regulations during 1996 to define consumer product areas that will be monitored to measure inflation and assess the convergence of national economies a precondition to monetary union. It will also determine the methods to be used in constructing new price indices - to be known as Harmonised Indices of Consumer Prices.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.